Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C17H15N3O2. It belongs to the cyclobutenedione class of compounds and features both a phenylethylamine and pyridinamide moiety attached to a cyclobutene dione core. The molecule has been catalogued in several chemical databases (DrugBank DB07234, ChEMBL466496, PDB Ligand ID: 793), but there is no evidence of clinical development or approved therapeutic use as of June 2025. Its mechanism of action and biological targets are not described in public sources; it remains an experimental compound with potential for diverse biological activities due to its structure[1][5][10].
- Other names
- 3-{[(1R)-1-phényléthyl]amino}-4-(4-pyridinylamino)-3-cyclobutène-1,2-dione3-Cyclobutene-1,2-dione, 3-[[(1R)-1-phenylethyl]amino]-4-(4-pyridinylamino)-3-{[(1R)-1-phényléthyl]amino}-4-(pyridin-4-yloxy)cyclobutène
02
Targets
MK2 (Mitogen-activated protein kinase-activated protein kinase 2)
Beyond the preview
Go deeper on 3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione.